More than 300 million people worldwide live with a rare disease, representing up to 5.9% of the global population. With over 6,000 distinct conditions, 72% of which are genetic, the therapeutic landscape is uniquely complex. For these patients, the primary barrier to life-changing care is not simply a lack of medicine, but a fragmented healthcare system that often fails to connect them with the right specialists in time.